| Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis. | |
| | |
MedLine Citation:
|
PMID: 21083142 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
The plasma proteome offers a wealth of opportunity to develop protein-based assays for diagnostic, prognostic and predictive biomarkers. Nonetheless, the unique properties of plasma, with its high dynamic range of protein concentrations and the vast complexity of protein species, present considerable analytical challenges. The continuing maturation of proteomic technologies, in particular biological MS instrumentation and immunoaffinity sample preparation strategies, is driving progress in the field. Selected reaction monitoring (SRM)-MS of peptides derived from plasma proteins is one such development that facilitates high-fidelity selection and quantitation with only minimal prior sample enrichment, while coupling targeted immunoaffinity enrichment prior to SRM-MS further enhances detection of less-abundant plasma proteins present in the subnanogram per millilitre concentration. This article reviews recent progress in the bioanalysis of plasma proteins driven by SRM-MS. |
| | |
Authors:
|
Chi-Li Chiu; Sarah Randall; Mark P Molloy |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Bioanalysis Volume: 1 ISSN: 1757-6199 ISO Abbreviation: Bioanalysis Publication Date: 2009 Jul |
Date Detail:
|
Created Date: 2010-11-18 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101512484 Medline TA: Bioanalysis Country: England |
Other Details:
|
Languages: eng Pagination: 847-55 Citation Subset: IM |
Affiliation:
|
Department of Chemistry & Biomolecular Sciences and Australian Proteome Analysis Facility, Macquarie University, Sydney 2109, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Metabolite quantitation: detector technology and MIST implications.
Next Document: Society spotlight: Spotlight on the calibration and validation group.